University of California, Los Angeles
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private, Subsidiary
- Established
- 1919-05-23
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucla.edu
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
Phase 3
Completed
- Conditions
- Heroin DependenceMorphine DependenceSubstance Withdrawal Syndrome
- First Posted Date
- 2002-04-08
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 163
- Registration Number
- NCT00032955
- Locations
- ๐บ๐ธ
Phoenix House, New York, New York, United States
๐บ๐ธBetty Ford Center, Rancho Mirage, California, United States
๐บ๐ธThe Center For Drug-Free Living, Orlando, Florida, United States
Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled Trial
Phase 3
Completed
- Conditions
- Memory Disorders
- First Posted Date
- 2001-01-24
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00009230
- Locations
- ๐บ๐ธ
UCLA Neuropsychiatric Institute, Los Angeles, California, United States
Randomized Study of Intensive One-on-one Behavioral Treatment for Preschool Aged Children With Autism
Not Applicable
Completed
- Conditions
- Autistic Disorder
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 102
- Registration Number
- NCT00004449
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-01-29
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 12
- Registration Number
- NCT00000299
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Multicenter Clinical Trial of Buprenorphine - 3
Phase 3
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00000207
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Buprenorphine Maintenance Protocol - 1
Phase 3
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00000205
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Feasibility Study of Take-Home LAAM Medication - 3
Phase 4
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-11-01
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00000300
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00000301
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Clinical Rescue Protocol - 2
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-11-06
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00000206
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2016-07-11
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00000303
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath